Status:
UNKNOWN
Epidemiologic, Clinical, Molecular Characteristics of Hospital Employees With or Without Covid-19 Infection
Lead Sponsor:
Istituto Clinico Humanitas
Conditions:
COVID
Eligibility:
All Genders
18+ years
Brief Summary
The study cohort will be enrolled among all Humanitas group employees (including ICH, Humanitas University and Gavazzeni), and two validation cohorts. Participants will be asked consent for the resear...
Detailed Description
The analysis will include: * study the expression levels of molecules known to mediated viral infection, like the Angiotensin converting enzyme 2 (ACE2) and genetic variants in these genes, which cou...
Eligibility Criteria
Inclusion
- 1\. Individuals aged ≥ 18 years;
Exclusion
- 1\. Lack of informed consent according to local procedure per critically ill patients.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04451577
Start Date
June 1 2020
End Date
June 1 2023
Last Update
June 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Humanitas reseach hospital (ICH)
Rozzano, Milan, Italy, 20089